Feed SMTI
SM

Sanara MedTech Inc.

SMTI · NASDAQ

$35.17 +0.06% (+$0.02)
1M +2.30%
Market Cap $323.3M
P/E Ratio -
Div. Yield -
ROE 473.55%

Bulios Fair Price

$22.56

35.9% downside

Trenutna cena

$35.17

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica SMTI trenutno precenjena glede na svojo tržno ceno. Kako deluje?

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Piotroski F-Score Moderate
5/9
Valuation
8 /100
Expensive
EV/EBITDA 37.68x
P/S 2.94x
P/B 40.70x
Growth
78 /100
Growing
Rev. growth 31.03%
Book val. growth 47.86%
EPS growth N/A
Profitability
41 /100
Moderate
Gross margin 91.33%
Net margin 29.15%
Op. margin 9.36%
Quality
52 /100
Average
ROIC 18.02%
ROE 473.55%
ROA 46.30%
Debt
29 /100
High
Debt/Equity 6.11x
Current ratio 2.58x
Int. coverage 0.96x
Stability
43 /100
Moderate
Beta 1.16x
Rev. volatility 11.53%
EPS volatility 165.23%

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o SMTI
Online

O podjetju

Sanara MedTech Inc. is an American company focused on the development, manufacturing, and distribution of medical products for the treatment of chronic wounds and wound infections. Their portfolio includes a wide range of products, including dressings, hydrogels, creams, and other medical preparations that aid in wound healing and minimize the risk of infection. Sanara MedTech focuses on innovative therapeutic approaches and technologies that provide effective and gentle solutions for patients with chronic wounds or wounds caused by injuries or surgical procedures. Their products are designed to provide optimal support for healing and minimize the time needed for patient recovery.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Seth D. Yon

Employees

108

Headquarters

Fort Worth

Prihajajoči dogodki

11 NOV.

Earnings

Upcoming earnings report

50d
29 JUL.

Ex-Dividend

Ex-dividend date

310d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.